Phase II randomized trial of erlotinib or vinorelbine in chemonaive, advanced, non-small cell lung cancer patients aged 70 years or older.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Feb, 2012 | Pubmed ID: 22157367